|
COMMERCE BUSINESS DAILY ISSUE OF AUGUST 3,1998 PSA#2150National Institutes of Health, National Institute of Allergy and
Infectious Diseases, Contract Management Branch, Solar Bldg., Room
3C07, 6003 Executive Blvd. MSC 7610, Bethesda, MD 20892-7610 A -- TUBERCULOSIS ANTI-MICROBIAL ACQUISITION AND COORDINATING FACILITY
SOL RFP-NIH-NIAID-DAIDS-99-05 DUE 111398 POC Ms. Joyce U. Sagami,
Contract Specialist, 301-496-7118 The Opportunistic Infections Research
Branch, Therapeutics Research Program, Division of AIDS, National
Institute of Allergy and Infectious Diseases (NIAID), NIH, has a
requirement to develop therapies for the treatment of AIDS and
associated opportunistic infections. The purpose of this RFP is to seek
responsible offers for establishment of drug screening capability. This
contract is to serve as the central facility for coordinating
acquisition and testing of novel compounds. RESTRICTIONS TO COMPETITION
This contract will involve the use of information on compounds, which
may be confidential and proprietary. All offerors except those deemed
by the Government to have an actual or apparent conflict of interest
are eligible to compete. Organizations that are, or subsidiaries to,
pharmaceutical or chemical companies (i.e., an organization which sells
drugs and/or chemicals to the general public for profit) are examples
of organizations that are excluded from competition. Documentation of
commercial interests, such as investors' prospectus or recent audit,
must be supplied in an offeror's business proposal. The Government
reserves the right to exclude any offeror. If there is ANY question
about potential conflicts or APPARENT conflicts, contact the
Contracting Officer. An Advance Understanding will be inserted in the
resultant contract stating that the NIAID shall be notified if the
Contractor's conflict of interest status has changed and that a
determination shall be made regarding the continuation of the contract.
It is anticipated that one cost reimbursement, completion type contract
will be awarded for a period of seven (7) years, beginning
approximately August 17, 1999. RFP NIH-NIAID-DAIDS-99-05 will be
available electronically on or about August 6, 1998, and may be
accessed through the NIAID Contract Management Branch (CMB) Home Page
by using the following electronic address and instructions: NIAID/CMB
Home Page (via the WWW): Use http://www.niaid.nih.gov/contract to
access the NIAID/CMB Home Page. Once at the NIAID/CMB Home Page, click
on the "RFPs" link and then click on "RFP NIH-NIAID-DAIDS-99-05."
Please note that the RFP for this acquisition has been revised to
include only the Work Statement, Deliverable and Reporting
Requirements, Special Requirements and Mandatory Qualification, if any,
the Technical Evaluation Criteria, and the Proposal Preparation
Instructions. All information required for the submission of an offer
will be contained in the electronic RFP package. Following proposal
submission and the initial review process, offerors comprising the
competitive range will be requested to provide additional documentation
to the Contracting Officer. Responses to this RFP will be due on
November 13, 1998. Any responsible offeror may submit a proposal which
will be considered by the Government. This advertisement does not
commit the Government to award a contract. Point of Contact: Joyce U.
Sagami, Contract Specialist Electronic mail address: js73b@nih.gov
Telephone: (301) 496-7118 FAX: (301) 402-0972 No collect calls will be
accepted. Posted 07/30/98 (W-SN230471). (0211) Loren Data Corp. http://www.ld.com (SYN# 0006 19980803\A-0006.SOL)
A - Research and Development Index Page
|
|